ASPEN-09

Study Details

Full Title

A Phase 1b/2, Open-label, Multicenter, Multi Arm Study of Evorpacept in Combination with Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)

Principal Investigator

Carey
Anders

Protocol Number

PRO00119152

NCT ID

NCT07007559

Phase

I/II

Enrollment Status

Open to Enrollment